147 related articles for article (PubMed ID: 18164319)
41. Identification and quantification of ibuprofen, naproxen, ketoprofen and diclofenac present in waste-waters, as their trimethylsilyl derivatives, by gas chromatography mass spectrometry.
Sebok A; Vasanits-Zsigrai A; Palkó G; Záray G; Molnár-Perl I
Talanta; 2008 Jul; 76(3):642-50. PubMed ID: 18585333
[TBL] [Abstract][Full Text] [Related]
42. Effects of acidic non-steroidal anti-inflammatory drugs on human cytochrome P450 4A11 activity: Roles of carboxylic acid and a sulfur atom in potent inhibition by sulindac sulfide.
Itoh H; Yamashita N; Kamijo S; Masuda K; Kato H; Yamaori S
Chem Biol Interact; 2023 Sep; 382():110644. PubMed ID: 37499995
[TBL] [Abstract][Full Text] [Related]
43. Indomethacin decreases optic nerve oxygen tension by a mechanism other than cyclo-oxygenase inhibition.
Noergaard MH; Pedersen DB; Bang K; Jensen PK; Kiilgaard JF; Stefánsson E; la Cour M
Br J Ophthalmol; 2008 Jan; 92(1):126-30. PubMed ID: 17965100
[TBL] [Abstract][Full Text] [Related]
44. NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs.
Nemmani KV; Mali SV; Borhade N; Pathan AR; Karwa M; Pamidiboina V; Senthilkumar SP; Gund M; Jain AK; Mangu NK; Dubash NP; Desai DC; Sharma S; Satyam A
Bioorg Med Chem Lett; 2009 Sep; 19(18):5297-301. PubMed ID: 19683923
[TBL] [Abstract][Full Text] [Related]
45. Altered pharmacokinetics of zalcitabine by concurrent use of NSAIDs in rats.
Oh YH; Han HK
Acta Pharmacol Sin; 2006 Jan; 27(1):119-22. PubMed ID: 16364218
[TBL] [Abstract][Full Text] [Related]
46. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
47. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
[TBL] [Abstract][Full Text] [Related]
48. Effects of some non-steroidal anti-inflammatory drugs (NSAIDS) on steroidogenesis in rat and porcine testis.
Kwan TK; Foong SL; Lim YT; Gower DB
Biochem Mol Biol Int; 1993 Nov; 31(4):733-43. PubMed ID: 8298502
[TBL] [Abstract][Full Text] [Related]
49. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
van Staa TP; Rietbrock S; Setakis E; Leufkens HG
J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
[TBL] [Abstract][Full Text] [Related]
50. In vivo phototoxicity of non-steroidal anti-inflammatory drugs evaluated by the mouse tail technique.
Ljunggren B; Lundberg K
Photodermatol; 1985 Dec; 2(6):377-82. PubMed ID: 4094928
[TBL] [Abstract][Full Text] [Related]
51. Stimuli-responsive antioxidant nanoprodrugs of NSAIDs.
Lee BS; Yuan X; Xu Q; McLafferty FS; Petersen BA; Collette JC; Black KL; Yu JS
Int J Pharm; 2009 May; 372(1-2):112-24. PubMed ID: 19166922
[TBL] [Abstract][Full Text] [Related]
52. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation.
Shaikh S; Nicholson LF
J Neurosci Res; 2008 Jul; 86(9):2071-82. PubMed ID: 18335520
[TBL] [Abstract][Full Text] [Related]
53. Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.
Gobec S; Brozic P; Rizner TL
Bioorg Med Chem Lett; 2005 Dec; 15(23):5170-5. PubMed ID: 16183274
[TBL] [Abstract][Full Text] [Related]
54. Mathematical approach to understand the kinetics of alpha-synuclein aggregation: relevance to Parkinson's disease.
Bharathi P; Nagabhushan P; Rao KS
Comput Biol Med; 2008 Oct; 38(10):1084-93. PubMed ID: 18823621
[TBL] [Abstract][Full Text] [Related]
55. An in vitro biomarker approach for the evaluation of the ecotoxicity of non-steroidal anti-inflammatory drugs (NSAIDs).
Parolini M; Binelli A; Cogni D; Riva C; Provini A
Toxicol In Vitro; 2009 Aug; 23(5):935-42. PubMed ID: 19426796
[TBL] [Abstract][Full Text] [Related]
56. Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay.
Kramer ML; Behrens C; Schulz-Schaeffer WJ
Biotechniques; 2008 Mar; 44(3):403-11. PubMed ID: 18361794
[TBL] [Abstract][Full Text] [Related]
57. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
Locke CJ; Fox SA; Caldwell GA; Caldwell KA
Neurosci Lett; 2008 Jul; 439(2):129-33. PubMed ID: 18514411
[TBL] [Abstract][Full Text] [Related]
58. Characterization of fibrillation process of alpha-synuclein at the initial stage.
Tashiro M; Kojima M; Kihara H; Kasai K; Kamiyoshihara T; Uéda K; Shimotakahara S
Biochem Biophys Res Commun; 2008 May; 369(3):910-4. PubMed ID: 18329380
[TBL] [Abstract][Full Text] [Related]
59. The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers.
Näsström T; Wahlberg T; Karlsson M; Nikolajeff F; Lannfelt L; Ingelsson M; Bergström J
Biochem Biophys Res Commun; 2009 Jan; 378(4):872-6. PubMed ID: 19070597
[TBL] [Abstract][Full Text] [Related]
60. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
